BioStable Science & Engineering
Latest round
- Series C
Last raised
- Feb 2020
Total raised
- $11M
Investors
- 5
About BioStable Science & Engineering
BioStable Science & Engineering, Inc.Founded in 2008, BioStable Science & Engineering, Inc. is based in Austin, US, and specializes in developing aortic valve repair technology. Since its inception, the firm has completed a total of 4 deals, with the most recent occurring on February 25, 2020.BioStable Science & Engineering specializes in advanced aortic valve repair technologies, focusing on the HAART 300™ and HAART 200™ aortic annuloplasty devices. These products are designed to resize and reshape the aortic valve annulus, aiming to reduce dilatation and stabilize the valve, thereby decreasing the risk of recurrent annular dilatation. The HAART 300™ targets trileaflet aortic valves, while the HAART 200™ is specifically engineered for bicuspid aortic valve restoration. These devices are utilized in various clinical settings, addressing conditions such as isolated aortic insufficiency, aortic aneurysms with aortic insufficiency, dissections with aortic insufficiency, and other related applications.The revenue model of BioStable Science & Engineering is primarily based on the direct sale of its flagship products, the HAART 300™ and HAART 200™ aortic annuloplasty devices, to hospitals and surgical centers that perform valve repair procedures. Transactions typically occur through a B2B structure, where the company establishes partnerships with medical institutions and surgical teams, facilitating training and support alongside device sales. Pricing structures are determined based on the specific needs of the healthcare facilities, which may include bulk purchasing agreements or individual device sales.BioStable Science & Engineering is focused on launching new products aimed at enhancing its aortic valve repair solutions, with plans for specific product releases in the near future. The company is targeting expansion into additional European and North American markets by 2023, aiming to establish new partnerships with medical institutions to broaden its reach.
Who invested in BioStable Science & Engineering
5 investors across 4 rounds
See all investors in BioStable Science & Engineering
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about BioStable Science & Engineering
Who invested in BioStable Science & Engineering?
BioStable Science & Engineering has 5 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioStable Science & Engineering raised?
BioStable Science & Engineering has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did BioStable Science & Engineering last raise money?
BioStable Science & Engineering's most recent round on record is a Series C, in Feb 2020.
What does BioStable Science & Engineering do?
BioStable Science & Engineering, Inc.
Where is BioStable Science & Engineering headquartered?
BioStable Science & Engineering is headquartered in Austin, US.
Which VCs invest in companies like BioStable Science & Engineering?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at BioStable Science & Engineering's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like BioStable Science & Engineering? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.